Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

Intercede Revenue Slumps as Exceptional Licence Sale Fades – IGP

Sep 02, 2025 | Team Kalkine
Intercede Revenue Slumps as Exceptional Licence Sale Fades – IGP
Image source: shutterstock

  • IGP:LSE
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (GBX)

INTERCEDE GROUP PLC

Intercede Group PLC (LSE: IGP) is an FTSE AIM All-Share listed cybersecurity specialist headquartered in the UK, develops digital identity solutions that help organizations prevent data breaches caused by compromised credentials. The company offers a modular product suite enabling customizable security implementations, ranging from secure user registration and identity verification to comprehensive password management systems.

Key Recommendation Rationale – Sell at GBX 176.00

  • Revenue Decline Following an Exceptional Prior Year: The company reported a decrease in revenue from £20.0 million to £17.7 million, an 11.5% year-on-year decline. While this is attributed to an exceptional £6 million perpetual licence in the prior year, it highlights a dependency on large, one-off deals for headline growth. The underlying performance, excluding this deal, suggests challenges in maintaining consistent top-line growth through its core recurring and subscription models alone.
  • Potential Over-reliance on Specific Government Contracts: A substantial portion of the reported contract renewals originates from a small number of U.S. federal agencies, with two renewals alone valued at over $2.4 million. This concentration creates client concentration risk, where any delay, budget cut, or change in procurement strategy within these agencies could have a material adverse effect on the company's financial performance.
  • Extended Sales Cycles and Government Procurement Uncertainties: The outlook statement acknowledges that "decision-making cycles within government entities continue to be longer compared to non-governmental sector." This inherent slowness in its primary market segment can lead to revenue recognition delays, difficulty in forecasting, and increased operational costs associated with maintaining long sales pipelines, potentially impacting cash flow predictability.

Valuation Methodology: Price/ Earnings Approach

 Share Price Chart  

One-Year Technical Price Chart (as of September 02, 2025). Source: REFINITIV, Analysis: Kalkine Group

Conclusion

The observed revenue decrease, following a previous period boosted by a single transaction, points to a variability in income streams that may be influenced by the timing and scale of occasional large deals. This pattern suggests that growth figures can be affected substantially by non-recurring events, making period-to-period comparisons less straightforward. Furthermore, the company's financial performance appears to be somewhat linked to its engagements with a limited number of major government agencies. This reliance on a specific client segment introduces a factor of vulnerability, as the company's results could be susceptible to shifts in public sector budgeting, extended procurement cycles, or policy changes within those governmental bodies.

For conducting the valuation, the following peers have been considered: Eleco PLC (LSE: ELCO), Quartix Technologies PLC (LSE: QTX), etc

Given its current trading levels, the recent strategic investments and partnerships, relative valuation, and associated risks, it is prudent to exit the stock at the current levels.

Hence, a ‘Sell’ recommendation is given on the stock at the Current Market Price of GBX 176.00 as of 02 September 2025 at 09:30 AM GMT +1.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 02 September 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level which the stock is expected to reach as per the relative valuation method and/or technical analysis taking into consideration both short-term and long-term scenario.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’


Disclaimer-

This report has been issued by Kalkine Limited (Company number 07903332), a private limited company, incorporated in England and Wales ("Kalkine”). Kalkine.co.uk and associated pages are published by Kalkine. Kalkine is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites.  All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain non personalized recommendations to invest in securities and other financial products.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Please also read our Terms & Conditions for further information. Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Kalkine Media Limited, an affiliate of Kalkine, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this report.

Past performance is not a reliable indicator of future performance.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions